Gary W. Arendash

12.0k total citations · 1 hit paper
117 papers, 9.7k citations indexed

About

Gary W. Arendash is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Gary W. Arendash has authored 117 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Physiology, 31 papers in Molecular Biology and 27 papers in Neurology. Recurrent topics in Gary W. Arendash's work include Alzheimer's disease research and treatments (48 papers), Neuroinflammation and Neurodegeneration Mechanisms (20 papers) and Neuroscience and Neuropharmacology Research (18 papers). Gary W. Arendash is often cited by papers focused on Alzheimer's disease research and treatments (48 papers), Neuroinflammation and Neurodegeneration Mechanisms (20 papers) and Neuroscience and Neuropharmacology Research (18 papers). Gary W. Arendash collaborates with scholars based in United States, Japan and United Kingdom. Gary W. Arendash's co-authors include Chuanhai Cao, David L King, Jun Tan, Jennifer R. Cracchiolo, Debra J. Socci, Roger A. Gorski, Marcia N. Gordon, David M. Diamond, Jaime M. Hatcher and C. Warren Olanow and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Gary W. Arendash

117 papers receiving 9.4k citations

Hit Papers

Aβ peptide vaccination prevents memory loss in an animal ... 2000 2026 2008 2017 2000 400 800 1.2k

Peers

Gary W. Arendash
Joseph Rogers United States
Botond Penke Hungary
Daniel C. Lee United States
Christian J. Pike United States
Gabriela Peña Argentina
Anne Eckert Switzerland
Stephen D. Ginsberg United States
Joseph Rogers United States
Gary W. Arendash
Citations per year, relative to Gary W. Arendash Gary W. Arendash (= 1×) peers Joseph Rogers

Countries citing papers authored by Gary W. Arendash

Since Specialization
Citations

This map shows the geographic impact of Gary W. Arendash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary W. Arendash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary W. Arendash more than expected).

Fields of papers citing papers by Gary W. Arendash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary W. Arendash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary W. Arendash. The network helps show where Gary W. Arendash may publish in the future.

Co-authorship network of co-authors of Gary W. Arendash

This figure shows the co-authorship network connecting the top 25 collaborators of Gary W. Arendash. A scholar is included among the top collaborators of Gary W. Arendash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary W. Arendash. Gary W. Arendash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arendash, Gary W. & Chuanhai Cao. (2023). Transcranial Electromagnetic Wave Treatment: A Fountain of Healthy Longevity?. International Journal of Molecular Sciences. 24(11). 9652–9652. 4 indexed citations
2.
Tajiri, Naoki, et al.. (2013). Traumatic Brain Injury Precipitates Cognitive Impairment and Extracellular Aβ Aggregation in Alzheimer's Disease Transgenic Mice. PLoS ONE. 8(11). e78851–e78851. 58 indexed citations
3.
Mori, T., Kavon Rezai‐Zadeh, Naoki Koyama, et al.. (2012). Tannic Acid Is a Natural β-Secretase Inhibitor That Prevents Cognitive Impairment and Mitigates Alzheimer-like Pathology in Transgenic Mice. Journal of Biological Chemistry. 287(9). 6912–6927. 140 indexed citations
5.
Echeverrı́a, Valentina, Ross Zeitlin, Sarah Burgess, et al.. (2011). Cotinine Reduces Amyloid-β Aggregation and Improves Memory in Alzheimer's Disease Mice. Journal of Alzheimer s Disease. 24(4). 817–835. 74 indexed citations
6.
Dragicevic, Natasa, Malgorzata Mamcarz, Yuyan Zhu, et al.. (2010). Mitochondrial Amyloid-β Levels are Associated with the Extent of Mitochondrial Dysfunction in Different Brain Regions and the Degree of Cognitive Impairment in Alzheimer's Transgenic Mice. Journal of Alzheimer s Disease. 20(s2). S535–S550. 168 indexed citations
7.
Arendash, Gary W. & Chuanhai Cao. (2010). Caffeine and Coffee as Therapeutics Against Alzheimer's Disease. Journal of Alzheimer s Disease. 20(s1). S117–S126. 140 indexed citations
8.
Cao, Chuanhai, Xiaoyang Lin, Chi Zhang, et al.. (2008). Mutant Amyloid-beta-sensitized dendritic cells as Alzheimer's disease vaccine. Journal of Neuroimmunology. 200(1-2). 1–10. 15 indexed citations
9.
Cracchiolo, Jennifer R., Takashi Mori, S. J. Nazian, et al.. (2007). Enhanced cognitive activity—over and above social or physical activity—is required to protect Alzheimer’s mice against cognitive impairment, reduce Aβ deposition, and increase synaptic immunoreactivity. Neurobiology of Learning and Memory. 88(3). 277–294. 128 indexed citations
10.
Costa, David A., Jennifer R. Cracchiolo, Adam D. Bachstetter, et al.. (2006). Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms. Neurobiology of Aging. 28(6). 831–844. 181 indexed citations
11.
Bjugstad, Kimberly B., William D. Flitter, & Gary W. Arendash. (2004). Intracerebroventricular Infusions of gp120 Inhibit Weight Gain and Induce Atrophy in the Hippocampus and Neostriatum Without Affecting Cognition. PubMed. 2(4). 15–31. 1 indexed citations
12.
Leighty, Ralph E., Lars Nilsson, Huntington Potter, et al.. (2004). Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer’s transgenic mouse lines differing in Aβ deposition. Behavioural Brain Research. 153(1). 107–121. 40 indexed citations
13.
Arendash, Gary W., Marcia N. Gordon, David M. Diamond, et al.. (2003). Short-term β-amyloid vaccinations do not improve cognitive performance in cognitively impaired APP+PS1 mice.. Behavioral Neuroscience. 117(3). 478–484. 35 indexed citations
14.
King, David L & Gary W. Arendash. (2002). Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment. Brain Research. 926(1-2). 58–68. 82 indexed citations
15.
Bjugstad, Kimberly B., William D. Flitter, William A. Garland, et al.. (2000). CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-α infusion model for AIDS dementia complex. Journal of NeuroVirology. 6(6). 478–491. 9 indexed citations
16.
Socci, Debra J., et al.. (1996). Antioxidant treatment with phenyl-α-tert-butyl nitrone (PBN) improves the cognitive performance and survival of aging rats. Neuroscience Letters. 205(3). 181–184. 71 indexed citations
18.
Olanow, C. Warren & Gary W. Arendash. (1994). Metals and free radicals in neurodegeneration. Current Opinion in Neurology. 7(6). 548–558. 154 indexed citations
19.
Arendash, Gary W., William J. Millard, Ralph Dawson, Adrian J. Dunn, & Edwin M. Meyer. (1989). Different long-term effects of bilateral and unilateral nucleus basalis lesions on rat cerebral cortical neurotransmitter content. Neurochemical Research. 14(11). 1113–1118. 20 indexed citations
20.
Arendash, Gary W. & Peter C. K. Leung. (1986). Alleviation of Estrogen-Induced Hyperprolactinemia through Intracerebral Transplantation of Hypothalamic Tissue Containing Dopaminergic Neurons. Neuroendocrinology. 43(3). 359–367. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026